drug

SON-1010

Phase 1updated 3mo ago

by Sonnet BioTherapeutics Holdings Inc

Phase 1

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying SON-1010

phase2Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancerterminatedn=40
phase1Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumorsactive not recruitingn=42
EP1Study of SON-1010 (IL12-FHAB) in Healthy Adultscompletedn=32

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 9m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

SON-1010

Phase 1updated 3mo ago

by Sonnet BioTherapeutics Holdings Inc

Phase 1

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying SON-1010

phase2Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancerterminatedn=40
phase1Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumorsactive not recruitingn=42
EP1Study of SON-1010 (IL12-FHAB) in Healthy Adultscompletedn=32

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 9m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

SON-1010

indications

all catalysts(0)

Trials studying SON-1010

News(0)

Report a data issue

comments(0)

SON-1010

indications

all catalysts(0)

Trials studying SON-1010

News(0)

Report a data issue

comments(0)